A Phase 2, Open-Label, Randomized Controlled Trial Evaluating Safety and Efficacy of Dose-Intensified Versus Standard Dosing Regimens of [ 177 Lu]Lu-PSMA-597 in mCRPC (OPTIMAL-PSMA)
Sobia Khan, Nathan Papa, Takanori Hioki, Megan Crumbaker et autres
0 citationsJournal of Nuclear Medicine